Actin­o­mycin D CAS 50-76-0

Iden­ti­fi­ca­tion
Prop­er­ties
Safe­ty Data
Spec­i­fi­ca­tions and Oth­er Information
Links

Iden­ti­fi­ca­tion

CAS Number

50-76-0

Name

Actin­o­mycin

Syn­onyms

2-Amino-N,N’-bis(6,13-diisopropyl-2,5,9-trimethyl-1,4,7,11,14-pentaoxooctadecahydrocyclopenta[i][1,4,7,13]oxatriazacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazin-1,9-dicarboxamid [Ger­man] [ACD/IUPAC Name]
2-Amino-N,N’-bis(6,13-diisopropyl-2,5,9-trimethyl-1,4,7,11,14-pentaoxooctadecahydrocyclopenta[i][1,4,7,13]oxatriazacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide [ACD/IUPAC Name]
2-Amino-N,N’-bis(6,13-diisopropyl-2,5,9-triméthyl-1,4,7,11,14-pentaoxooctadécahydrocyclopenta[i][1,4,7,13]oxatriazacyclohexadécin-10-yl)-4,6-diméthyl-3-oxo-3H-phénoxazine-1,9-dicarboxamide [French] [ACD/IUPAC Name]
3H-Phenoxazine-1,9-dicarboxamide, 2-amino-4,6-dimethyl-N1,N9-bis[octadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxocyclopent[i][1,4,7,13]oxatriazacyclohexadecin-10-yl]-3-ox
o- [ACD/​Index Name]
50-76-0 [RN]
Dactin­o­mycin [USP] [Wiki]

Mol­e­c­u­lar Structure

Struc­ture of Actin­o­mycin D CAS 50-76-0

SMILES

Cc1ccc(c2c1oc-3c(c(=O)c(c(c3n2)C(=O)NC4C(OC(=O)C(N(C(=O)CN(C(=O)C5CCCC5C(=O)C(NC4=O)C(C)C)C)C)C(C)C)C)N)C)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCC7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C

Std­InChI

InChI=1S/C64H88N10O16/c1-27(2)44-53(78)35-19-17-21-37(35)61(84)71(13)25-40(75)73(15)50(29(5)6)63(86)88-33(11)46(59(82)67-44)69-57(80)39-24-23-31(9)55-48(39)66-49-42(43(65)52(77)32(10)56(49)90-55)58(81)70-47-34(12)89-64(87)51(30(7)8)74(16)41(76)26-72(14)62(85)38-22-18-20-36(38)54(79)45(28(3)4)68-60(47)83/h23-24,27-30,33-38,44-47,50-51H,17-22,25-26,65H2,1-16H3,(H,67,82)(H,68,83)(H,69,80)(H,70,81)

Std­InChIKey

HWIXWKQRE­ITWRB-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C64H88N10O16

Mol­e­c­u­lar Weight

1253.44

EINECS

200-063-6

Beil­stein Reg­istry Number

605235

MDL Number

MFCD00005033

Prop­er­ties

Appear­ance

Bright red crys­talline powder

Melt­ing Point

251-253℃

Safe­ty Data

Sym­bol

Sig­nal Word

Dan­ger

Haz­ard Statements

H300

Pre­cau­tion­ary Statements

P264-P301 + P310

Per­son­al Pro­tec­tive Equipment

Eye­shields, Faceshields, full-face par­ti­cle res­pi­ra­tor type N100 (US), Gloves, res­pi­ra­tor car­tridge type N100 (US), type P1 (EN143) res­pi­ra­tor fil­ter, type P3 (EN 143) res­pi­ra­tor cartridges

RIDADR

UN 3462 6.1 / PGII

WGK Germany

3

RTECS

AU1575000

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Actin­o­mycin D CAS 50-76-0

Stan­dard

Enter­prise standard

Iden­ti­fi­ca­tion Methods

HNMR/HPLC

Puri­ty

98%min

Stor­age

store at the 2-8° and away from light

Appli­ca­tion

The prod­uct is effec­tive for malig­nant moles and is effec­tive for nephrob­las­toma, Hodgkin’s dis­ease, tes­tic­u­lar tumor, rhab­domyosar­co­ma, neu­rob­las­toma and retic­u­lum sar­co­ma. It also has a cer­tain effect on cer­vi­cal can­cer, ovar­i­an can­cer, breast can­cer and diges­tive tract can­cer. Com­bined with radio­ther­a­py can increase the sen­si­tiv­i­ty of radiotherapy.

Gen­er­al View of Documents

Links

This prod­uct is devel­oped by our RandD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttps://​www​.cam​ing​.com/​a​c​t​i​n​o​m​y​c​i​n​-​d​-​c​a​s​-​5​0​-​7​6​-0/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone).and D pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations.